Delivery Order 36F79722D0090-36C26025F0153
Award Date
2/26/25
Potential Completion Date
9/30/25
Potential Value
$111K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Grifols USA LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Mary, FL 32746, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Grifols USA LLC, a global healthcare company, is for the pharmaceutical product PROLASTIN-C LIQUID. The contract, valued at $11,502.40, is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). PROLASTIN-C is an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The contract has a firm fixed price and an ultimate completion date of August 23, 2024. Grifols USA LLC holds a Federal...
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Grifols USA LLC, a global healthcare company that specializes in plasma-derived medicines and pharmaceutical supplies. The contract, which is not a set-aside, is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, with a ceiling value of $288,931.30 and a completion date of September 30, 2024. Grifols USA LLC holds a Federal...
This is a delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20), a regional network within the U.S. Department of Veterans Affairs (VA), to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract is for the supply of PROLASTIN-C, a drug product, and has a ceiling value of $100,281.60. The contract was awarded on a Firm Fixed Price basis under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB)...
The Department of Veterans Affairs Veterans Health Administration awarded a $109,200 delivery order contract to Grifols USA LLC under the company's Pharmaceuticals and Drugs Federal Supply Schedule. The contract calls for Grifols to provide PROLASTIN-C, a drug used to treat alpha-1 antitrypsin deficiency, to facilities located in Los Angeles, California. The base period of performance is one year, from February 8, 2024 through February 7, 2025. Pricing is firm fixed. No subcontractors or...
This is a $319,369.68 delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract, which is not set aside, is for the delivery of the pharmaceutical product PROLASTIN C. It is a firm fixed price contract with a period of performance ending on September 30, 2020. Grifols Therapeutics LLC is a long-standing federal contractor, having...
This federal contract award is to Grifols USA LLC, a global healthcare company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of PROLASTIN, a pharmaceutical product, with a potential value of $59,192.70. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is priced on a firm fixed price basis. The contract does not have a set-aside designation. Grifols USA LLC is the prime contractor...
This federal contract award is for the delivery of PROLASTIN-C 1000MG VIALS to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to Grifols USA LLC, a global healthcare company that specializes in the development, manufacturing, and distribution of plasma-derived medicines and pharmaceutical supplies. The contract is a Delivery Order under Grifols' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the supply of PROLASTIN-C PHARMACEUTICALS and is issued under the VA's Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The contract has a ceiling value of $94,800.00 and a period of performance ending on September 30, 2015. The contract does not utilize any small...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $223,184.16, is for the provision of PROLASTIN C, a pharmaceutical product, to the VA under the Pharmaceuticals and Drugs GSA Schedule contract. The contract is a firm fixed-price delivery order with a period of performance ending on September 30, 2017. The contract was...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $84,612.48, was issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and involves the procurement of various pharmaceutical products such as Prolastin, Prolastin-C, and immune globulin. The contract has an ultimate completion date of May 25, 2017 and does...